Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesQuality of life and depression among metastatic breast cancer patients
Medical Oncology, 10/05/09
Slovacek L et al. – The pilot study evaluated the level of the global quality of life (QoL) and the incidence and the relevance of the depression among metastatic breast cancer patients in a programme of palliative cancer care. The results showed that subsist association between metastatic breast cancer, depression, and the low level of the global QoL.
Methods- Study is prospective and cross-sectional
- Dates obtained during year 2008 among 41 patients
- mean age of all 41 subjects was 58 years old (aged 41–80 years old)
- The Czech version of Zung self-rating depression scale performed for evaluation of depression
- Czech version of generic European Quality of Life Questionnaire EQ-5D performed for evaluation of level of global QoL
- Statistical evaluation presents that mean ZSDS (Zung self-rating depression score) certifies presence of signs of moderate depression among metastatic breast cancer patients (ZSDS range was 60–69)
- Incidence of depression was 61% (25 of all 41 subjects)
- Relevance of depression is characterized: the severe depression was proved in 5 of all 25 subjects, the moderate depression in 10 of all 25 subjects, and the mild depression in 10 of all 25 subjects
- Global QoL among metastatic breast cancer patients is very low level
- Mean EQ-5D score (dimension of QoL) was 55%
- Mean EQ-5D VAS (subjective health status) was 59.2%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status
British Journal of Cancer, 03/19/10
Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode
Breast Cancer Research and Treatment, 03/19/10
Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells
Breast Cancer Research and Treatment, 03/19/10
Article Search
Sponsor
Sponsor